IMMP · NASDAQ
IMMUTEP (IMMP) Stock Price & Fundamentals
IMMUTEP (IMMP) closed at $245.05 on Oct 9, 2026, down 1.28% from the previous close of $248.22.
Share price, past year
1Y +3.43%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $245.05 |
| Sep 30, 2026 | $240.90 |
| Aug 31, 2026 | $239.43 |
| Jul 31, 2026 | $246.21 |
| Jun 30, 2026 | $252.22 |
| May 29, 2026 | $261.99 |
| Apr 30, 2026 | $256.18 |
| Mar 31, 2026 | $244.99 |
| Feb 27, 2026 | $249.11 |
| Jan 30, 2026 | $248.18 |
| Dec 31, 2025 | $235.44 |
| Nov 28, 2025 | $244.11 |
| Oct 31, 2025 | $235.23 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 1.5B
- Dividend yield
- —
- 52-week range
- $231.33 – $264.41
Market cap, P/E and dividend yield aren't shown for IMMUTEP yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Australian dollars.
Financials
IMMUTEP reported revenue of A$10.33M for fiscal 2025, up 31.80% from fiscal 2024.
Figures are in Australian dollars (AUD), as IMMUTEP reports them to the SEC.
IMMUTEP reported a net loss of A$61.43M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Jun 30, 2025 | A$10.33M | +31.8% | −A$61.43M | −594.6% | −A$0.0422 | −A$62.10M |
| FY2024ended Jun 30, 2024 | A$7.84M | +50.7% | −A$42.72M | −545.0% | −A$0.0356 | −A$34.85M |
| FY2023ended Jun 30, 2023 | A$5.20M | −23.1% | −A$39.90M | −767.2% | −A$0.0447 | −A$35.44M |
| FY2022ended Jun 30, 2022 | A$6.76M | +70.3% | −A$32.21M | −476.6% | −A$0.0379 | −A$30.25M |
| FY2021ended Jun 30, 2021 | A$3.97M | −76.0% | −A$29.90M | −753.6% | −A$0.0503 | −A$17.66M |
| FY2020ended Jun 30, 2020 | A$16.50M | +120.3% | −A$13.47M | −81.6% | −A$0.0326 | −A$10.86M |
| FY2019ended Jun 30, 2019 | A$7.49M | +1.9% | −A$18.34M | −244.9% | −A$5.29 | −A$15.33M |
| FY2018ended Jun 30, 2018 | A$7.35M | +74.2% | −A$12.75M | −173.3% | −A$4.63 | −A$7.79M |
| FY2017ended Jun 30, 2017 | A$4.22M | +108.1% | −A$9.37M | −221.9% | −A$0.40 | −A$8.51M |
| FY2016ended Jun 30, 2016 | A$2.03M | — | −A$62.02M | −3,056.6% | −A$2.78 | −A$11.34M |
Company profile
- Name
- IMMUTEP Ltd
- Ticker
- IMMP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Level 32, Suite 32.07 Australia Square, 264 George Street, Sydney,, C3 NSW 2000
- Incorporated in
- C3
- Fiscal year ends
- June
- SEC CIK
- 0001506184
Recent SEC filings
- Oct 24, 2025
- Oct 22, 2024
- Oct 24, 2023
- Oct 31, 2022
- Oct 25, 2021
- Sep 25, 2020
- Sep 23, 2019
- Oct 19, 2018
Frequently asked questions
What is IMMUTEP's stock price?
IMMUTEP (IMMP) closed at $245.05 on Oct 9, 2026, down 1.28% from the previous close of $248.22.
How much revenue does IMMUTEP make?
IMMUTEP reported revenue of A$10.33M for fiscal 2025, up 31.80% from fiscal 2024.
Sources and methodology
Fundamentals come from IMMUTEP Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures